Bill > HR4434

This bill aims to enhance supply chain transparency and safety in the cosmetic industry by amending the Federal Food, Drug, and Cosmetic Act. The legislation introduces comprehensive requirements for cosmetic manufacturers, brand owners, and suppliers to provide detailed information about cosmetic ingredients and potential health risks. Key provisions include mandating that suppliers provide brand owners with extensive information about cosmetic ingredients, such as their functions, potential health hazards, chemical properties, and safety data. The bill establishes a process for the FDA to create and maintain a list of potentially harmful "nonfunctional constituents" that may be present in cosmetics, with an advisory committee helping to develop this initial list. Suppliers will be required to conduct testing for these constituents and provide certificates of analysis to brand owners, detailing the levels of such substances and their testing methods. The bill also allows states to maintain or implement their own cosmetic ingredient regulations that provide greater transparency or protection. Additionally, the legislation establishes a framework for the FDA to request supply chain information in cases where a cosmetic product is suspected of being adulterated or misbranded, with potential civil penalties of up to $10,000 per day for companies that fail to comply with the new reporting and testing requirements.

Business and Industry

https://www.congress.gov/bill/119th-congress/house-bill/4434/all-info